Antimicrobial precious-metal nanoparticles and their use in novel materials

Recent Patents on Food, Nutrition and Agriculture

Volumn 4, Issue 3, 2012, Pages 200-209

  Senior, Katharina ^a   Müller, Stefanie ^a   Schacht, Veronika J ^a,b   Bunge, Michael ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Ag; Antifouling; Au; Biocidal nanoparticles; Biofouling; Coating; Gold; Growth inhibition; Microorganisms; MRSA; Silver; Surface; VRE

Indexed keywords

ANTIINFECTIVE AGENT; METAL; METAL NANOPARTICLE;

ARTICLE; FOOD SAFETY; HUMAN; MATERIALS; NANOMEDICINE; NANOTECHNOLOGY; PATENT;

ANTI-INFECTIVE AGENTS; FOOD SAFETY; HUMANS; MANUFACTURED MATERIALS; METAL NANOPARTICLES; METALS; NANOMEDICINE; NANOTECHNOLOGY; PATENTS AS TOPIC;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84870442630     PISSN: 22127984     EISSN: 18761429     Source Type: Journal    
DOI: 10.2174/2212798411204030200     Document Type: Article

References (149)

1. Alvarez LH, Cervantes FJ. (Bio) nanotechnologies to enhance environmental quality and energy production. J Chem Technol Biot 2011;86(11):1354-63.
2. Banerjee I, Pangule RC, Kane RS. Antifouling coatings: Recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms. Adv Mater 2011;23(6):690-718.
3. Caruthers SD, Wickline SA, Lanza GM. Nanotechnological applications in medicine. Curr Opin Biotech 2007;18(1):26-30. (Pubitemid 46227971)
4. Duncan TV. Applications of nanotechnology in food packaging and food safety: Barrier materials, antimicrobials and sensors. J Colloid Interf Sci 2011;363(1):1-24.
5. Engel E, Michiardi A, Navarro M, Lacroix D, Planell JA. Nanotechnology in regenerative medicine: The materials side. Trends Biotechnol 2008;26(1):39-47. (Pubitemid 350298598)
6. Lee J, Mahendra S, Alvarez P J J. Nanomaterials in the construction industry: A review of their applications and environmental health and safety considerations. ACS Nano 2010;4(7):3580-90.
7. Park B. Current and future applications of nanotechnology. In: Hester RE, Harrison RM, editors. Nanotechnology: consequences for human health and the environment. Cambridge, UK: RSC Publishing; 2007. p. 1-18.
8. Theron J, Walker JA, Cloete TE. Nanotechnology and water treatment: Applications and emerging opportunities. Crit Rev Microbiol 2008;34(1):43-69. (Pubitemid 351225501)
9. Nel AE, Mädler L, Velegol D, Xia T, Hoek E M V, Somasundaran P, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009;8(7):543-57.
10. Ahn SJ, Lee SJ, Kook JK, Lim BS. Experimental antimicrobial orthodontic adhesives using nanofillers and silver nanoparticles. Dent Mater 2009;25(2):206-13.
11. Eby DM, Luckarift HR, Johnson GR. Hybrid antimicrobial enzyme and silver nanoparticle coatings for medical instruments. ACS Appl Mater Interfaces 2009;1(7):1553-60.
12. Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, et al. Silver nanoparticles and polymeric medical devices: A new approach to prevention of infection? J Antimicrob Chemoth 2004;54(6):1019-24. (Pubitemid 40136734)
13. Lara HH, Garza-Trevino EN, Ixtepan-Turrent L, Singh DK. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnol 2011;9:30.
14. Schneider OD, Loher S, Brunner TJ, Schmidlin P, Stark WJ. Flexible, silver containing nanocomposites for the repair of bone defects: Antimicrobial effect against E. coli infection and comparison to tetracycline containing scaffolds. J Mater Chem 2008;18(23):2679-84.
15. Stevens K N J, Crespo-Biel O, van den Bosch E E M, Dias AA, Knetsch M L W, Aldenhoff Y B J, et al. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood. Biomaterials 2009;30(22):3682-90.
16. Taylor E, Webster TJ. Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine 2011;6:1463-73.
17. Zhao LZ, Wang HR, Huo KF, Cui LY, Zhang WR, Ni HW, et al. Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials 2011;32(24):5706-16.
18. Dal Lago V, de Oliveira LF, Goncalves KD, Kobarg J, Cardoso MB. Size-selective silver nanoparticles: future of biomedical devices with enhanced bactericidal properties. J Mater Chem 2011;21(33):12267-73.
19. Liu JY, Sonshine DA, Shervani S, Hurt RH. Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 2010;4(11):6903-13.
20. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, et al. Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem 2007;12(4):527-34. (Pubitemid 46686142)
21. Martinez-Castanon GA, Nino-Martinez N, Martinez-Gutierrez F, Martinez-Mendoza JR, Ruiz F. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanopart Res 2008;10(8):1343-8.
22. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science 2006;311(5761):622-7. (Pubitemid 43191298)
23. Neal AL. What can be inferred from bacterium-nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles? Ecotoxicology 2008;17(5):362-71.
24. Pelletier DA, Suresh AK, Holton GA, McKeown CK, Wang W, Gu BH, et al. Effects of engineered cerium oxide nanoparticles on bacterial growth and viability. Appl Environ Microbiol 2010;76(24):7981-9.
25. Ju-Nam Y, Lead JR. Manufactured nanoparticles: An overview of their chemistry, interactions and potential environmental implications. Sci Total Environ 2008;400(1-3):396-414.
26. Jiang JK, Oberdörster G, Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 2009;11(1):77-89.
27. Padmavathy N, Vijayaraghavan R. Enhanced bioactivity of ZnO nanoparticles - an antimicrobial study. Sci Technol Adv Mater 2008;9(3):035004.
28. Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, et al. The potential risks of nanomaterials: A review carried out for ECETOC. Part Fibre Toxicol 2006;3:11.
29. Bunge M, Søbjerg LS, Rotaru AE, Gauthier D, Lindhardt AT, Hause G, et al. Formation of palladium (0) nanoparticles at microbial surfaces. Biotechnol Bioeng 2010;107(2):206-15.
30. Korbekandi H, Iravani S, Abbasi S. Production of nanoparticles using organisms. Crit Rev Biotechnol 2009;29(4):279-306.
31. Lloyd JR, Byrne JM, Coker VS. Biotechnological synthesis of functional nanomaterials. Curr Opin Biotech 2011;22(4):509-15.
32. Mandal D, Bolander ME, Mukhopadhyay D, Sarkar G, Mukherjee P. The use of microorganisms for the formation of metal nanoparticles and their application. Appl Microbiol Biot 2006;69(5):485-92. (Pubitemid 41830856)
33. Thakkar KN, Mhatre SS, Parikh RY. Biological synthesis of metallic nanoparticles. Nanomed-Nanotechnol 2010;6(2):257-62.
34. Klaine SJ, Alvarez P J J, Batley GE, Fernandes TF, Handy RD, Lyon DY, et al. Nanomaterials in the environment: Behavior, fate, bioavailability, and effects. Environ Toxicol Chem 2008;27(9):1825-51.
35. Marambio-Jones C, Hoek E M V. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 2010;12(5):1531-51.
36. Su HL, Chou CC, Hung DJ, Lin SH, Pao IC, Lin JH, et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 2009;30(30):5979-87.
37. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, et al. Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species. J Phys Chem B 2008;112(43):13608-19.
38. Choi O, Hu ZQ. Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ Sci Technol 2008;42(12):4583-8. (Pubitemid 351842410)
39. Bae E, Park HJ, Lee J, Kim Y, Yoon J, Park K, et al. Bacterial cytotoxicity of the silver nanoparticle related to physicochemical metrics and agglomeration properties. Environ Toxicol Chem 2010;29(10):2154-60.
40. Jin X, Li MH, Wang JW, Marambio-Jones C, Peng FB, Huang XF, et al. High-throughput screening of silver nanoparticle stability and bacterial inactivation in aquatic media: Influence of specific ions. Environ Sci Technol 2010;44(19):7321-8.
41. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J Colloid Interf Sci 2004;275(1):177-82. (Pubitemid 38670216)
42. AshaRani PV, Mun G L K, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009;3(2):279-90.
43. Amato E, Diaz-Fernandez YA, Taglietti A, Pallavicini P, Pasotti L, Cucca L, et al. Synthesis, characterization and antibacterial activity against Gram positive and Gram negative bacteria of biomimetically coated silver nanoparticles. Langmuir 2011;27(15):9165-73.
44. Egger S, Lehmann RP, Height MJ, Loessner MJ, Schuppler M. Antimicrobial properties of a novel silver-silica nanocomposite material. Appl Environ Microbiol 2009;75(9):2973-6.
45. Fabrega J, Fawcett SR, Renshaw JC, Lead JR. Silver nanoparticle impact on bacterial growth: Effect of pH, concentration, and organic matter. Environ Sci Technol 2009;43(19):7285-90.
46. Fernandez EJ, Garcia-Barrasa J, Laguna A, Lopez-de-Luzuriaga JM, Monge M, Torres C. The preparation of highly active antimicrobial silver nanoparticles by an organometallic approach. Nanotechnology 2008;19(18):185602.
47. Gottesman R, Shukla S, Perkas N, Solovyov LA, Nitzan Y, Gedanken A. Sonochemical coating of paper by microbiocidal silver nanoparticles. Langmuir 2011;27(2):720-6.
48. Guzman M, Dille J, Godet S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomed-Nanotechnol 2012;8(1):37-45.
49. Huang LY, Dai TH, Xuan Y, Tegos GP, Hamblin MR. Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: Efficacy against bacterial burn infections. Antimicrob Agents Ch 2011;55(7):3432-8.
50. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: Development of an antimicrobial gel formulation for topical use. Mol Pharm 2009;6(5):1388-401.
51. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomed-Nanotechnol 2007;3(1):95-101. (Pubitemid 46428190)
52. Lalueza P, Monzon M, Arruebo M, Santamaria J. Bactericidal effects of different silver-containing materials. Mater Res Bull 2011;46(11):2070-6.
53. Li WR, Xie XB, Shi QS, Zeng HY, Ou-Yang YS, Chen YB. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biot 2010;85(4):1115-22.
54. Oei JD, Zhao WW, Chu LR, DeSilva MN, Ghimire A, Rawls HR, et al. Antimicrobial acrylic materials with in situ generated silver nanoparticles. J Biomed Mater Res B 2012;100B (2): 409-15.
55. Ruparelia JP, Chatteriee AK, Duttagupta SP, Mukherji S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 2008;4(3):707-16. (Pubitemid 351461288)
56. Travan A, Pelillo C, Donati I, Marsich E, Benincasa M, Scarpa T, et al. Non-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity. Biomacromolecules 2009;10(6):1429-35.
57. Benn T, Cavanagh B, Hristovski K, Posner JD, Westerhoff P. The release of nanosilver from consumer products used in the home. J Environ Qual 2010;39(6):1875-82.
58. Wijnhoven S W P, Peijnenburg W J GM, Herberts CA, Hagens WI, Oomen AG, Heugens E H W, et al. Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009;3(2):109-38.
59. Damm C, Münstedt H. Kinetic aspects of the silver ion release from antimicrobial polyamide/silver nanocomposites. Appl Phys A - Mater 2008;91(3):479-86.
60. Liu JY, Hurt RH. Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ Sci Technol 2010;44(6):2169-75.
61. Dhawan A, Sharma V, Parmar D. Nanomaterials: A challenge for toxicologists. Nanotoxicology 2009;3(1):1-9.
62. Römer I, White TA, Baalousha M, Chipman K, Viant MR, Lead JR. Aggregation and dispersion of silver nanoparticles in exposure media for aquatic toxicity tests. J Chromatogr A 2011;1218(27):4226-33.
63. Liu SB, Wei L, Hao L, Fang N, Chang MW, Xu R, et al. Sharper and faster "nano darts" kill more bacteria: A study of antibacterial activity of individually dispersed pristine single-walled carbon nanotube. ACS Nano 2009;3(12):3891-902.
64. Harrison JJ, Ceri H, Turner RJ. Multimetal resistance and tolerance in microbial biofilms. Nat Rev Microbiol 2007;5(12):928-38. (Pubitemid 350131181)
65. Nies DH. Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol Rev 2003;27(2-3):313-39. (Pubitemid 36700434)
66. Schacht VJ, Neumann LV, Sandhi SK, Chen L, Henning T, Klar PJ, et al. Effects of silver nanoparticles on microbial growth dynamics. J Appl Microbiol, in press 2012.
67. Singh M, Singh S, Prasad S, Gambhir IS. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Dig J Nanomater Bios 2008;3(3):115-22.
68. Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2007;2(4):Mr17-Mr71.
69. Duran N, Marcato PD, De Souza G I H, Alves OL, Esposito E. Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their effluent treatment. J Biomed Nanotechnol 2007;3(2):203-8. (Pubitemid 351877171)
70. Edwards-Jones V. The benefits of silver in hygiene, personal care and healthcare. Lett Appl Microbiol 2009;49(2):147-52.
71. Kokura S, Handa O, Takagi T, Ishikawa T, Naito Y, Yoshikawa T. Silver nanoparticles as a safe preservative for use in cosmetics. Nanomed-Nanotechnol 2010;6(4):570-4.
72. Li Y, Leung P, Yao L, Song QW, Newton E. Antimicrobial effect of surgical masks coated with nanoparticles. J Hosp Infect 2006;62(1):58-63. (Pubitemid 43103011)
73. Ip M, Lui SL, Poon V K M, Lung I, Burd A. Antimicrobial activities of silver dressings: An in vitro comparison. J Med Microbiol 2006;55(1):59-63. (Pubitemid 43031239)
74. Kostenko V, Lyczak J, Turner K, Martinuzzi RJ. Impact of silvercontaining wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Ch 2010;54(12):5120-31.
75. Lee HY, Park HK, Lee YM, Kim K, Park SB. A practical procedure for producing silver nanocoated fabric and its antibacterial evaluation for biomedical applications. Chem Commun 2007; (28): 2959-61. (Pubitemid 47053863)
76. Nguyen TH, Kim YH, Song HY, Lee BT. Nano Ag loaded PVA nano-fibrous mats for skin applications. J Biomed Mater Res B 2011;96B (2): 225-33.
77. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliver Rev 2011;63(6):470-91.
78. Rujitanaroj PO, Pimpha N, Supaphol P. Wound-dressing materials with antibacterial activity from electrospun gelatin fiber mats containing silver nanoparticles. Polymer 2008;49(21):4723-32.
79. Tian J, Wong K K Y, Ho CM, Lok CN, Yu WY, Che CM, et al. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007;2(1):129-36.
80. Zahedi P, Rezaeian I, Ranaei-Siadat SO, Jafari SH, Supaphol P. A review on wound dressings with an emphasis on electrospun nanofibrous polymeric bandages. Polym Advan Technol 2010;21(2):77-95.
81. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007;73(6):1712-20. (Pubitemid 46449051)
82. Malcher M, Volodkin D, Heurtault B, Andre P, Schaaf P, Möhwald H, et al. Embedded silver ions-containing liposomes in polyelectrolyte multilayers: Cargos films for antibacterial agents. Langmuir 2008;24(18):10209-15.
83. Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: A study against gram-positive and gram-negative bacteria. Nanomed-Nanotechnol 2010;6(1):103-9.
84. Li P, Li J, Wu CZ, Wu QS, Li J. Synergistic antibacterial effects of p-lactam antibiotic combined with silver nanoparticles. Nanotechnology 2005;16(9):1912-7. (Pubitemid 41107865)
85. Nanda A, Saravanan M. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomed-Nanotechnol 2009;5(4):452-6.
86. Ruden S, Hilpert K, Berditsch M, Wadhwani P, Ulrich AS. Synergistic interaction between silver nanoparticles and membranepermeabilizing antimicrobial peptides. Antimicrob Agents Ch 2009;53(8):3538-40.
87. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed-Nanotechnol 2007;3(2):168-71. (Pubitemid 46899614)
88. Esteban-Tejeda L, Malpartida F, Esteban-Cubillo A, Pecharroman C, Moya JS. The antibacterial and antifungal activity of a soda-lime glass containing silver nanoparticles. Nanotechnology 2009;20(8):085103.
89. Kim KJ, Sung WS, Moon SK, Choi JS, Kim JG, Lee DG. Antifungal effect of silver nanoparticles on dermatophytes. J Microbiol Biotechnol 2008;18(8):1482-4.
90. Chopra I. The increasing use of silver-based products as antimicrobial agents: A useful development or a cause for concern? J Antimicrob Chemoth 2007;59(4):587-90. (Pubitemid 47073388)
91. Mühling M, Bradford A, Readman JW, Somerfield PJ, Handy RD. An investigation into the effects of silver nanoparticles on antibiotic resistance of naturally occurring bacteria in an estuarine sediment. Mar. Environ Res 2009;68(5):278-83.
92. Stepanauskas R, Glenn TC, Jagoe CH, Tuckfield RC, Lindell AH, King CJ, et al. Coselection for microbial resistance to metals and antibiotics in freshwater microcosms. Environ Microbiol 2006;8(9):1510-4. (Pubitemid 44167977)
93. Stepanauskas R, Glenn TC, Jagoe CH, Tuckfield RC, Lindell AH, McArthur JV. Elevated microbial tolerance to metals and antibiotics in metal-contaminated industrial environments. Environ Sci Technol 2005;39(10):3671-8. (Pubitemid 40705491)
94. Bhattacharya R, Mukherjee P. Biological properties of "naked" metal nanoparticles. Adv Drug Deliver Rev 2008;60(11):1289-306.
95. Panyala NR, Pena-Mendez EM, Havel J. Gold and nano-gold in medicine: overview, toxicology and perspectives. J Appl Biomed 2009;7(2):75-91.
96. Zhao YY, Tian Y, Cui Y, Liu WW, Ma WS, Jiang XY. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. J Am Chem Soc 2010;132(35):12349-56.
97. Rai A, Prabhune A, Perry CC. Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J Mater Chem 2010;20(32):6789-98.
98. Das SK, Das AR, Guha AK. Gold Nanoparticles: Microbial Synthesis and Application in Water Hygiene Management. Langmuir 2009;25(14):8192-9.
99. Chen WY, Lin JY, Chen WJ, Luo LY, Diau E W G, Chen YC. Functional gold nanoclusters as antimicrobial agents, for antibioticresistant bacteria. Nanomedicine 2010;5(5):755-64.
100. dos Santos MM, Queiroz MJ, Baptista PV. Enhancement of antibiotic effect via gold: silver-Alloy nanoparticles. J Nanopart Res 2012;14(5):859.
101. Pornpattananangkul D, Zhang L, Olson S, Aryal S, Obonyo M, Vecchio K, et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc 2011;133(11):4132-9.
102. Langley S, Beveridge TJ. Metal binding by Pseudomonas aeruginosa PAO1 is influenced by growth of the cells as a biofilm. Can J Microbiol 1999;45(7):616-22.
103. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005;13(1):34-40. (Pubitemid 40082395)
104. Teitzel GM, Parsek MR. Heavy metal resistance of biofilm and planktonic Pseudomonas aeruginosa. Appl Environ Microbiol 2003;69(4):2313-20. (Pubitemid 36443652)
105. Bjarnsholt T, Kirketerp-Møller K, Kristiansen S, Phipps R, Nielsen AK, Jensen PO, et al. Silver against Pseudomonas aeruginosa biofilms. APMIS 2007;115(8):921-8. (Pubitemid 47256284)
106. Dancer SJ. Importance of the environment in methicillin-resistant Staphylococcus aureus acquisition: The case for hospital cleaning. Lancet Infect Dis 2008;8(2):101-13.
107. Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: A global perspective. Curr Opin Infect Dis 2010;23(6):546-53.
108. Machado MC, Cheng D, Tarquinio KM, Webster TJ. Nanotechnology: Pediatric Applications. Pediatr Res 2010;67(5):500-4.
109. Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemoth 2008;61(4):869-76. (Pubitemid 351426072)
110. Tran N, Webster TJ. Nanotechnology for bone materials. WIREs Nanomedicine and Nanobiotechnology 2009;1(3):336-51.
111. de Azeredo H M C. Nanocomposites for food packaging applications. Food Res Int 2009;42(9):1240-53.
112. Fernandez A, Picouet P, Lloret E. Cellulose-silver nanoparticle hybrid materials to control spoilage-related microflora in absorbent pads located in trays of fresh-cut melon. Int J Food Microbiol 2010;142(1-2):222-8.
113. Morris VJ. Emerging roles of engineered nanomaterials in the food industry. Trends Biotechnol 2011;29(10):509-16.
114. Jiang HQ, Manolache S, Wong A C L, Denes FS. Plasma-enhanced deposition of silver nanoparticles onto polymer and metal surfaces for the generation of antimicrobial characteristics. J Appl Polym Sci 2004;93(3):1411-22. (Pubitemid 38832014)
115. Loher S, Schneider OD, Maienfisch T, Bokorny S, Stark WJ. Micro-organism-triggered release of silver nanoparticles from biodegradable oxide carriers allows preparation of self-sterilizing polymer surfaces. Small 2008;4(6):824-32. (Pubitemid 352007149)
116. Perelshtein I, Applerot G, Perkas N, Guibert G, Mikhailov S, Gedanken A. Sonochemical coating of silver nanoparticles on textile fabrics (nylon, polyester and cotton) and their antibacterial activity. Nanotechnology 2008;19(24):245705.
117. Gallant-Behm CL, Yin HQ, Liu SJ, Heggers JP, Langford RE, Olson ME, et al. Comparison of in vitro disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy. Wound Rep Regen 2005;13(4):412-21. (Pubitemid 41060423)
118. Fong J, Wood F. Nanocrystalline silver dressings in wound management: A review. Int J Nanomed 2006;1(4):441-9.
119. Bhattacharyya M, Bradley H. A case report of the use of nanocrystalline silver dressing in the management of acute surgical site wound infected with MRSA to prevent cutaneous necrosis following revision surgery. Int J Low Extrem Wounds 2008;7(1):45-8. (Pubitemid 351364432)
120. Crane M, Handy RD, Garrod J, Owen R. Ecotoxicity test methods and environmental hazard assessment for engineered nanoparticles. Ecotoxicology 2008;17(5):421-37.
121. Stone V, Nowack B, Baun A, van den Brink N, von der Kammer F, Dusinska M, et al. Nanomaterials for environmental studies: Classification, reference material issues, and strategies for physicochemical characterisation. Sci Total Environ 2010;408(7):1745-54.
122. Albrecht MA, Evans CW, Raston CL. Green chemistry and the health implications of nanoparticles. Green Chem 2006;8(5):417-32. (Pubitemid 43739257)
123. Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and in vitro studies: The need of the hour. Toxicol Appl Pharm 2012;258(2):151-65.
124. Kreyling WG, Semmler-Behnke M, Möller W. Health implications of nanoparticles. J Nanopart Res 2006;8(5):543-62. (Pubitemid 44744640)
125. Oberdörster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 2010;267(1):89-105.
126. Papp T, Schiffmann D, Weiss D, Castranova V, Vallyathan V, Rahman Q. Human health implications of nanomaterial exposure. Nanotoxicology 2008;2(1):9-27.
127. Stern ST, McNeil SE. Nanotechnology safety concerns revisited. Toxicol Sci 2008;101(1):4-21. (Pubitemid 350239008)
128. Xia T, Li N, Nel AE. Potential health impact of nanoparticles. Annu Rev Publ Health 2009;30:137-50.
129. Phillips ML. Gut Reaction Environmental Effects on the Human Microbiota. Environ Health Persp 2009;117(5):A198-A205.
130. Xiu ZM, Zhang QB, Puppala HL, Colvin VL, Alvarez PJ. Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 2012;12(8):4271-5.
131. Sugiura, K. Method for antimicrobial processing of ceramic ware using antimicrobial composition for glaze. WO2012002205 (2012).
132. Difrancesco, A. G. Silver antimicrobial composition with extended shelf-life. US20110293683 (2011).
133. Ylitalo, C. M., Stepanova, N. Y., Sebastian, J. M., Belgrade, S. K., Holm, D. R., Li, F. B. Antimicrobial electret web. US20110290119 (2011).
134. Holladay, R. J., Moeller, W., Mehta, D., Roy, R., Brooks, J. H. J., Mortenson, M. G. Silver/water, silver gels and silver-based compositions; and methods for making and using the same. US20110262556 (2011).
135. Klein, B. K., Katzner, L. D. Antimicrobial and immunostimulating composition. US20110244021 (2011).
136. Ohrlander M, Sodervall B, Antimicrobial substrates and uses thereof. US20110236441 (2011).
137. Doye, C., Krüger, U., Pyritz, U. Component with an antimicrobial surface and use thereof US20110229728 (2011).
138. Gogotsi, Y., Lee, B. Y., Behler, K., Rest, R. Metal or metal oxide deposited fibrous materials. US20110192789 (2011).
139. Olson ME, Allan ND, Omar AM, Anderson JJ, Nadworny PL, Harding MW, Silver (III) periodates for preventing or reducing microbial contamination, and method for their synthesis. WO2011072392 (2011).
140. Weiss T, Xalter R, Nano silver-zinc oxide composition. WO2011023584 (2011).
141. Ninagawa M, Durable antimicrobial agent for fiber product having antiviral effect. JP2011042642 (2011).
142. Faucher, K. M., Kabiru, H., Horton, A., Richard, P. J., Martakos, P. Anti-infective antimicrobial-containing biomaterials. WO2011019834 (2011).
143. Roe, P., Jobe, M., Novick, M. System and method for using nanoparticles for antimicrobial activity. US20110038909 (2011).
144. Sabesan, S. Antimicrobial solid surface materials containing chitosan-metal complexes. US8092815 (2012).
145. McClure, D. J., Perez, M. A. Method of transferring nanoparticles using a microporous article having metallic nanoparticle coating. US8062701 (2011).
146. Golubev, V. N., Kolenkov, I. A., Sleptsov, V. V., Tjanginskij, A. J., Tserulev, M. V., Shmidt, V. I. Biocidal concentrate. RU2422377C2 (2011).
147. Anderson, K. S., Gaddam, B. N., Pocius. A. V., Yarwood, J. M. Antimicrobial nanoparticles. EP2288659 (2011).
148. Borrelli, N. F., Morse, D. L., Senaratne, W., Verrier, F., Wei, Y. Coated, antimicrobial, chemically strengthened glass and methods of making. US20120034435 (2012).
149. Chang, H., Cheah, C. M., Leo, J., Leung, H. Anti-microbial coatings, coating solutions and methods of producing the same. WO2012015362 (2012).